Skip to main content
. 2012 Jan;340(1):11–18. doi: 10.1124/jpet.111.186858

Fig. 4.

Fig. 4.

Representative tracings depicting the changes in AP and HR elicited by intracisternal WIN55,212-2 (15 μg/rat) in conscious animals pretreated with vehicle (A), the PI3K inhibitor wortmannin (Wort; 0.4 μg/rat) (B), or the MEK/ERK1/2 inhibitor PD98059 (PD98; 5 μg/rat) (C).